Company
Headquarters: Toronto, ON, Canada
CEO: Chris Savoie
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
The Hash Corporation focuses on the production and sale of cannabis-based hashish and other cannabis products. The company was formerly known as Senternet Phi Gamma Inc. and changed its name to The Hash Corporation in July 2019. The Hash Corporation was incorporated in 1967 and is headquartered in Toronto, Canada.
The Hash Corp has the following listings and related stock indices.
Stock: CSE: REZN